<- Go Home
M3, Inc.
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists, recruitment, and posting job advertisements through m3.com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Market Cap
JPY 1.0T
Volume
3.9M
Cash and Equivalents
JPY 148.1B
EBITDA
JPY 68.9B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
JPY 142.6B
Profit Margin
57.52%
52 Week High
JPY 2.5K
52 Week Low
JPY 1.1K
Dividend
N/A
Price / Book Value
2.90
Price / Earnings
25.97
Price / Tangible Book Value
5.00
Enterprise Value
JPY 906.4B
Enterprise Value / EBITDA
12.72
Operating Income
JPY 59.0B
Return on Equity
12.12%
Return on Assets
7.75
Cash and Short Term Investments
JPY 148.1B
Debt
JPY 24.4B
Equity
JPY 364.4B
Revenue
JPY 247.9B
Unlevered FCF
JPY 40.4B
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium